JP Morgan Chase’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-100
Closed -$6K 6630
2021
Q1
$6K Buy
+100
New +$4.53K ﹤0.01% 5849

Other funds holding VCEL

JP Morgan Chase's VCEL Position: Q2 2026 in Review

JP Morgan Chase reduced its Vericel Corp (VCEL) stake by 8.8% in Q2 2026, selling an estimated $1.03M and leaving 297,759 shares worth $13.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2548.

JP Morgan Chase first reported a position in VCEL in Q2 2016 and has held it in 37 quarters since. The position peaked at $45.7M in Q2 2021. 320 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

  • JP Morgan Chase held 297,759 shares of Vericel Corp worth $13.5M as of Q2 2026.
  • JP Morgan Chase sold 28,671 Vericel Corp shares in Q2 2026, an estimated $1.03M.
  • Vericel Corp made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2548 holding.
  • JP Morgan Chase first reported a position in Vericel Corp in Q2 2016 and has held it in 37 quarters since.
  • JP Morgan Chase's Vericel Corp position peaked at $45.7M in Q2 2021.
  • 320 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.